{"DataElement":{"publicId":"6676372","version":"1","preferredName":"Treatment Cohort Study 10248 Code","preferredDefinition":"The code that represents the information pertaining to protocol 10248 in which subsets of a defined population are identified.","longName":"TX_COH_SDY_10248_CD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"2497526","version":"1","preferredName":"Treatment Cohort Study","preferredDefinition":"Information pertaining to studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"TX_COHORT_STDY","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2416951","version":"1","preferredName":"Therapy","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"02DBEE3F-243E-103A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-10-12","modifiedBy":"ONEDATA","dateModified":"2005-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2497524","version":"1","preferredName":"Cohort Study","preferredDefinition":"Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"C15208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort Study","conceptCode":"C15208","definition":"A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FC9E-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"ONEDATA","dateModified":"2006-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FCAF-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"SOKKERL","dateModified":"2017-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6676364","version":"1","preferredName":"10248 Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"6676364v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"250","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"SG6","valueDescription":"SG6: Phase 2 PI-refractory (Cohort 2)","ValueMeaning":{"publicId":"6676365","version":"1","preferredName":"SG6: Phase 2 PI-refractory (Cohort 2)","longName":"6676365","preferredDefinition":"SG6: Phase 2 PI-refractory (Cohort 2)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"845F1CF0-B2AB-2BB9-E053-F662850AEB9B","latestVersionIndicator":"Yes","beginDate":"2019-03-18","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-03-18","modifiedBy":"ONEDATA","dateModified":"2019-03-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"845F1CF0-B2C4-2BB9-E053-F662850AEB9B","beginDate":"2019-03-18","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-03-18","modifiedBy":"ONEDATA","dateModified":"2019-03-18","deletedIndicator":"No"},{"value":"SG5","valueDescription":"SG5: Phase 2 PI-non-refractory (Cohort 1); Standard-risk; Prior therapy = 2 or more lines","ValueMeaning":{"publicId":"6676366","version":"1","preferredName":"SG5: Phase 2 PI-non-refractory (Cohort 1); Standard-risk; Prior therapy = 2 or more lines","longName":"6676366","preferredDefinition":"SG5: Phase 2 PI-non-refractory (Cohort 1); Standard-risk; Prior therapy = 2 or more lines","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"845F1CF0-B2CE-2BB9-E053-F662850AEB9B","latestVersionIndicator":"Yes","beginDate":"2019-03-18","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-03-18","modifiedBy":"ONEDATA","dateModified":"2019-03-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"845F1CF0-B2E7-2BB9-E053-F662850AEB9B","beginDate":"2019-03-18","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-03-18","modifiedBy":"ONEDATA","dateModified":"2019-03-18","deletedIndicator":"No"},{"value":"SG4","valueDescription":"SG4: Phase 2 PI-non-refractory (Cohort 1); Standard-risk; Prior therapy = 1 line","ValueMeaning":{"publicId":"6676367","version":"1","preferredName":"SG4: Phase 2 PI-non-refractory (Cohort 1); Standard-risk; Prior therapy = 1 line","longName":"6676367","preferredDefinition":"SG4: Phase 2 PI-non-refractory (Cohort 1); Standard-risk; Prior therapy = 1 line","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"845F1CF0-B2F1-2BB9-E053-F662850AEB9B","latestVersionIndicator":"Yes","beginDate":"2019-03-18","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-03-18","modifiedBy":"ONEDATA","dateModified":"2019-03-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"845F1CF0-B30A-2BB9-E053-F662850AEB9B","beginDate":"2019-03-18","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-03-18","modifiedBy":"ONEDATA","dateModified":"2019-03-18","deletedIndicator":"No"},{"value":"SG3","valueDescription":"SG3: Phase 2 PI-non-refractory (Cohort 1); High-risk; Prior therapy = 2 or more lines","ValueMeaning":{"publicId":"6676368","version":"1","preferredName":"SG3: Phase 2 PI-non-refractory (Cohort 1); High-risk; Prior therapy = 2 or more lines","longName":"6676368","preferredDefinition":"SG3: Phase 2 PI-non-refractory (Cohort 1); High-risk; Prior therapy = 2 or more lines","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"845F1CF0-B314-2BB9-E053-F662850AEB9B","latestVersionIndicator":"Yes","beginDate":"2019-03-18","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-03-18","modifiedBy":"ONEDATA","dateModified":"2019-03-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"845F1CF0-B32D-2BB9-E053-F662850AEB9B","beginDate":"2019-03-18","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-03-18","modifiedBy":"ONEDATA","dateModified":"2019-03-18","deletedIndicator":"No"},{"value":"SG2","valueDescription":"SG2: Phase 2 PI-non-refractory (Cohort 1); High-risk; Prior therapy = 1 line","ValueMeaning":{"publicId":"6676369","version":"1","preferredName":"SG2: Phase 2 PI-non-refractory (Cohort 1); High-risk; Prior therapy = 1 line","longName":"6676369","preferredDefinition":"SG2: Phase 2 PI-non-refractory (Cohort 1); High-risk; Prior therapy = 1 line","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"845F1CF0-B337-2BB9-E053-F662850AEB9B","latestVersionIndicator":"Yes","beginDate":"2019-03-18","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-03-18","modifiedBy":"ONEDATA","dateModified":"2019-03-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"845F1CF0-B350-2BB9-E053-F662850AEB9B","beginDate":"2019-03-18","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-03-18","modifiedBy":"ONEDATA","dateModified":"2019-03-18","deletedIndicator":"No"},{"value":"SG1","valueDescription":"SG1: Phase 1 Dose Escalation","ValueMeaning":{"publicId":"6676370","version":"1","preferredName":"SG1: Phase 1 Dose Escalation","longName":"6676370","preferredDefinition":"SG1: Phase 1 Dose Escalation","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"845F1CF0-B35A-2BB9-E053-F662850AEB9B","latestVersionIndicator":"Yes","beginDate":"2019-03-18","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-03-18","modifiedBy":"ONEDATA","dateModified":"2019-03-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"845F1CF0-B373-2BB9-E053-F662850AEB9B","beginDate":"2019-03-18","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-03-18","modifiedBy":"ONEDATA","dateModified":"2019-03-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4386398","version":"1","preferredName":"Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic.:A system of numbered categories for representation of data.","longName":"C61512:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort","conceptCode":"C61512","definition":"A group of individuals, identified by a common characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE558C16-1C27-C6A8-E040-BB89AD430BEE","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-07-16","modifiedBy":"ONEDATA","dateModified":"2014-07-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"845F1CF0-B293-2BB9-E053-F662850AEB9B","latestVersionIndicator":"Yes","beginDate":"2019-03-18","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-03-18","modifiedBy":"SOKKERL","dateModified":"2020-02-18","changeDescription":"3/18/19ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Subgroup","type":"Preferred Question Text","description":"Subgroup","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"845FA585-9FF7-2643-E053-F662850A9771","latestVersionIndicator":"Yes","beginDate":"2019-03-18","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-03-18","modifiedBy":"SOKKERL","dateModified":"2020-02-18","changeDescription":"3/18/19ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}